$0.60
arrow_drop_up15.38%Key Stats | |
---|---|
Open | $0.54 |
Prev. Close | $0.52 |
EPS | -0.37 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $18.39M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.53 | 0.63 |
52 Week Range | 0.46 | 6.36 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.37 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
BriaCell Presents Clinical Efficacy Data at ASCO 2024
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
BriaCell Announces Oral and Poster Presentations at ASCO 2024
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies